Trends in glycaemic control and drug use in males and females with type 2 diabetes: Results of the Australian National Diabetes Audit from 2013 to 2019.
Angie S XiangNaomi SzwarcbardDanijela GasevicArul EarnestAnthony PeaseSof AndrikopoulosNatalie WischerWendy DavisSophia ZoungasPublished in: Diabetes, obesity & metabolism (2021)
From 2013 to 2019, mean HbA1c levels remained unchanged despite a concurrent increase in the number of antihyperglycaemic medications used. Overall, there was a trend towards preferencing newer agents with some differences in treatment regimens relating to sex and renal function.